1. Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript  Motley Fool
2. Pfizer Earnings Top Estimates as New CEO Bourla Takes Reins  Bloomberg
3. Vaccine and blood thinner help drive Pfizer to quarterly earnings beat  Yahoo Finance
4. Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript  Seeking Alpha
5. Pfizer 1Q profit jumps 9% on higher drug sales, lower costs  KIRO Seattle
6. View full coverage on Google News

1. What You Must Know About Pfizer Inc.?s (NYSE:PFE) Financial Strength  Simply Wall St
2. Pfizer Inc. (PFE) Holdings Cut by Neumann Capital Management LLC  Mayfield Recorder
3. Pendal Group Ltd Raises Holdings in Pfizer Inc. (NYSE:PFE)  Tech Know Bits
4. Igniting Curiosity on This Name, Investor Update on Pfizer Inc. (NYSE:PFE)  Hermann Herald
5. P2 Capital Partners Holds Holding in Brinks Co (BCO); Pfizer (PFE) Holder Bowling Portfolio Management Trimmed Its Stake  The NBO News
6. View full coverage on Google News

Of the 6 largest pharmaceutical companies by market cap, Pfizer is the most balanced and with the shallowest patent cliff. Its best selling drugs are immune to.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (?KSF?), announces that KSF has commenced ...

Pfizer Inc. is a global biopharma giant with a 3.5% dividend yield and a broad portfolio of therapies and consumer healthcare products. Pfizer has invested in R.

The last five years were good for Pfizer shareholders. Here's how the next five could be different.

Pfizer announced that it had achieved positive top-line results from its phase 3 study using abrocitinb to treat patients with atopic dermatitis (eczema). Top-l.

Pfizer obtained FDA approval for drugs Vyndaqel and Vyndamax to treat patients with transthyretin amyloid cardiomyopathy. Vyndaqel and Vyndamax are the ...

AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger?

Pfizer Inc. (PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 years of ...

If you're looking to add a big pharma stock to your portfolio, Eli Lilly (NYSE:LLY) and Pfizer (NYSE:PFE) are naturally two top candidates. Both big drugmakers ...

Pfizer acquires private biotech Therachon to gain a clinical product, known as TA-46, to treat patients with Achondroplasia. Pfizer paid an upfront payment of $

Pfizer (NYSE:PFE) recently reported its Q1 2019 results, which were above our estimates. This note details the company's Q1 performance, and Trefis' forecast ...

Pfizer's new portfolio of prescription drugs lifted sales during the first quarter as the company said it continues to make progress on growing through its internal ...

The Food and Drug Administration (FDA) often sends new drug applications back to pharmaceutical companies with requests for more evidence. Recently ...

Pfizer stock has fallen harder than other drug makers this year. News has been upbeat with a drug approval and earnings beat. Is Pfizer a buy right now?

NEW YORK?In an effort to address the growing controversy surrounding widespread non-medical use of their products, pharmaceutical giant Pfizer released a ...

The FDA has approved Pfizer's (PFE +1.2%) Fragmin (dalteparin sodium) injection to reduce the recurrence of symptomatic venous thromboembolism (VTE) in ...

Federal authorities say 20 companies, including Teva, Sandoz and Pfizer, illegally conspired to hike generic drug prices.

It's unclear whether health insurers and PBMs will cover Pfizer's $225000 a year drug tafamidis to treat a rare heart disease.

Verily, Alphabet's health and life sciences division, is moving into the clinical trials market. It just announced strategic alliances with Novartis, Sanofi, Otsuka and ...

NEW YORK (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral drug, tafamidis, to treat a rare and fatal heart disease ...

A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.

Pfizer posted stronger-than-expected first quarter earnings Tuesday, and boosted the mid-point of its full-year profit forecast thanks to anticipated gains in ...

Which big pharma stock is more likely to be the bigger winner over the long run?

Shares of Pfizer (PFE - Get Report) posted gains on Thursday after the drugmaker was named a "top pick" at Credit Suisse following a meeting the analysts had ...

Pfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks ...

The three big pharmaceutical companies ? Eli Lilly, Merck, and Pfizer ? are due to release their results on Tuesday. Although health care had a fairly good ...

Investors considering a purchase of Pfizer Inc (Symbol: PFE) stock, but cautious about paying the going market price of $40.60/share, might benefit.

Pfizer's upcoming data reveal created a perfect sell the news event for Sarepta. The road to DMD drug greatness is strewn with failures as Pfizer has a lot to p.

Pfizer will pay $340 million upfront to acquire a private biotech, taking over development of an experimental dwarfism therapy that will pit the giant drugmaker ...

Four giant companies now dominate global vaccine sales. With newer and more expensive vaccines becoming available, the market value of vaccines could ...

Pfizer said Wednesday its experimental JAK1 inhibitor succeeded in a pivotal eczema study, although safety questions remain largely unanswered in a sparse ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, ...

Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit ...

Both Merck stock and Pfizer stock are were on the rise Tuesday morning after reporting first-quarter earnings, while Eli Lilly stock slipped into the red following ...

Here are the biggest calls on Wall Street on Thursday: Goldman Sachs upgraded Macy's to 'neutral' from 'sell'. Goldman said the underperformance of the stock ...

Pfizer earnings and Merck earnings beat, with the Dow drug giants giving decent outlooks. Pfizer stock, Merck stock rose. Eli Lilly stock fell on revenue.

Buy Pfizer stock on this current round of weakness. As Credit Suisse knows, the underpinnings are bullish for 2020 and beyond.

For Immediate Release. Chicago, IL ?May 15, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...

Pfizer has racked up a positive slate of Phase III data for its anti-?inflammatory JAK1 inhibitor abrocitinib (PF-?04965842), which the pharma giant is hoping to ...

Pfizer, Inc. ( PFE ) will begin trading ex-dividend on May 09, 2019. A cash dividend payment of $0.36 per share is scheduled to be paid on June 07,.

FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs.

To reduce costs, errors and inefficiencies, Pfizer and other pharmaceutical companies have joined a blockchain project led by technology company Chronicled, ...

Home · Canavan Disease Therapeutics Swot Analysis Of Leading Key Players | Pfizer IncTuring Pharmaceuticals AG? May 26, 2019 Researchunt General ...

Pfizer expects the Food and Drug Administration to decide in July on approval of tafamidis in the rare disease transthyretin amyloid cardiomyopathy. Assuming ...

A ribbon-cutting ceremony held last Thursday morning celebrated Pfizer's new 175000-square-foot clinical manufacturing facility at the company's campus on ...

Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft ...

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Over the past 10 years Pfizer Inc.

Pfizer's (PFE) investigational eczema treatment abrocitinib succeeds in pivotal late-stage study.

Check out the companies making headlines before the bell: Walmart ? The retail giant reported adjusted quarterly profit of $1.13 per share, 11 cents a share ...

Happy Monday, readers. I hope you've had a wonderful weekend. Alright, I'll come clean up top? This sort of is about the royal baby. But only as a point of ...

You might say Lidia Fonseca has been solving problems since she was a little girl. Born in Mexico, Fonseca moved to the U.S. when she was 10. ?I learned to ...

The "Halftime Report" traders answer viewer questions on Pioneer, Pfizer, J&J, FedEx and Foot Locker.

New Jersey Better Educational Savings Trust decreased its stake in Pfizer Inc (PFE) by 29.03% based on its latest 2018Q4 regulatory filing with the SEC.

Grassi Investment Management increased its stake in Pfizer Inc (PFE) by 17.17% based on its latest 2018Q4 regulatory filing with the SEC. Grassi Investment ...

The Global Dibigatran market report is a most important research for who looks for complete information on the Dibigatran market. The report covers all ...

Shares of Pfizer rose 1.7% in premarket trade Tuesday after the company reported first-quarter earnings and revenue that beat expectations, while raising its...

Wilbanks Smith & Thomas Asset Management Llc decreased its stake in Pfizer Inc (PFE) by 5.74% based on its latest 2018Q4 regulatory filing with the SEC.

CCI in a tweet confirmed about the approval of the JV.The proposed combination involves acquisition of Pfizer's consumer healthcare business by GSK.

Aqr Capital Management Llc increased its stake in Pfizer Inc (PFE) by 88.53% based on its latest 2018Q4 regulatory filing with the SEC. Aqr Capital ...

In response to the US Food and Drug Administration's (FDA) proposal to not go back and rename certain biologics with nonsense suffixes, as it once said it ...

The report on the Global Nanoparticles ? Metal & Metal Oxides Market offers complete data on the Nanoparticles ? Metal & Metal Oxides market. Components ...

Pfizer will acquire Therachon to gain access to TA-46, the biotech's lead drug candidate for the treatment of achondroplasia. The deal sees Pfizer pay $370m ...

Connecticut is leading a 44-state coalition alleging price-fixing by 20 makers of generic drugs. Their lawsuit seeks payments of billions of dollars to these states.

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public *service*. FDA does not endorse ...

Looking at top Wall Street opinions, Pfizer Inc. (NYSE: PFE) has recently made its way into the research list of Citigroup ? signaling that their analyst's rating ...

Exact Sciences has begun to reap both the benefits and drawbacks since it kicked off a sales and marketing partnership with Pfizer late last year to help promote ...

Tb Alternative Assets Ltd decreased its stake in Facebook Inc (FB) by 61.01% based on its latest 2018Q4 regulatory filing with the SEC. Tb Alternative Assets ...

On April 30, Pfizer (PFE) reported first-quarter results. The company reported revenues of $13.12 billion in the first quarter, a YoY rise of 2% on a reported basis ...

Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.

Pfizer has selected the first candidates in its four-year-old alliance with Sosei Heptares, the UK unit of Japanese biotech Sosei Group, sparking a $3m milestone ...

Harvard Management Co Inc increased its stake in Microsoft Corp (MSFT) by 27.96% based on its latest 2018Q4 regulatory filing with the SEC. Harvard ...

NEW YORK-- -- First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer ...

(Reuters) - GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business will not lesson competition in Australia, the country's anti-trust regulator said on ...

The Earnings to Price yield of Pfizer Inc. (NYSE:PFE) is 0.049306. This is calculated by taking the earnings per share and dividing it by the last closing share ...

For Immediate Release. Chicago, IL ? May 6, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...

Pfizer Inc. (PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a ...

Companies with shares expected to trade actively in Tuesday's session include Alphabet, Western Digital, MGM Resorts International and GE.

Private Advisor Group Llc increased its stake in Celgene Corp (CELG) by 25.54% based on its latest 2018Q4 regulatory filing with the SEC. Private Advisor ...

It's unclear whether the lawsuit would be affected by a bill that would limit the attorney general's power to join out-of-state cases.

The report comes just days after shareholders met and celebrated the success that the New York-based pharmaceutical giant.

Pfizer announced that it is partnering with blockchain startup Chronicled to join MediLedger, a blockchain platform to streamline drug supply chain.

Thirteen medicines were recommended for approval at the committee's April 2019 meeting. - News - PharmaTimes.

Sadoff Investment Management Llc increased its stake in Fidelity Natl Information Sv (FIS) by 142.16% based on its latest 2018Q4 regulatory filing with the ...

In November the U.S. DSCSA legislation comes into force requiring returned pharmaceuticals to be verified. MediLedger offers one of the most popular DSCSA ...

After today's close, we will hear from Apple Inc. (AAPL). This morning, here are a few of the big names reporting.

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

NEW YORK--(BUSINESS WIRE)--. Data spans 10 therapies across 10 types of cancer. Pfizer Inc. (PFE) will present data across its industry-leading oncology ...

Nli International Inc increased its stake in Eastman Chem Co (EMN) by 31.1% based on its latest 2018Q4 regulatory filing with the SEC. Nli International Inc Fort ...

Pfizer's Xtandi market share in nonmetastatic, castration-resistant prostate cancer is double that of competitor Erleada's, company executives said Tuesday.

Opus Investment Management Inc decreased its stake in Intel Corp. (INTC) by 10.05% based on its latest 2018Q4 regulatory filing with the SEC.

Mountain Pacific Investment Advisers Inc increased its stake in Charles Riv Labs Intl Inc (CRL) by 70.34% based on its latest 2018Q4 regulatory filing with the ...

The FDA approved Pfizer and Merck KGaA's Bavencio in combination with Inlyta for the first-line treatment of patients with advanced kidney cancer. (Pfizer).

Top Health Care Stocks: JNJ: -0.51% PFE: -0.48% ABT: Flat MRK: +0.21% AMGN: Flat Leading health care stocks were mixed pre-market Friday. Early.

Oakmont Corp increased its stake in Cheniere Energy Inc (LNG) by 34.14% based on its latest 2018Q4 regulatory filing with the SEC. Oakmont Corp bought ...

Continental Advisors Llc decreased its stake in Pfizer Inc (PFE) by 5.36% based on its latest 2018Q4 regulatory filing with the SEC. Continental Advisors Llc ...

Verity Asset Management Inc increased its stake in Pfizer Inc (PFE) by 134.55% based on its latest 2018Q4 regulatory filing with the SEC. Verity Asset Mark ...

Yhb Investment Advisors Inc increased its stake in Pfizer Inc (PFE) by 13.36% based on its latest 2018Q4 regulatory filing with the SEC. Yhb Investment Argent ...

May 21 (Reuters) - Verily, Novartis, Otsuka, Pfizer And Sanofi: * VERILY FORMS STRATEGIC ALLIANCES WITH NOVARTIS, OTSUKA, PFIZER AND SANOFI ...